All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-LY1339 | Anti-GPR161 (CBLG1-200) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-200 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1340 | Anti-GPR161 (1B2) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 1B2 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1341 | Anti-GPR161 (CBLG1-1632) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-1632 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY1342 | Anti-GPR161 (CBLG1-1633) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-1633 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2979 | Anti-GPR161(CBLG1-200) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-200 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2980 | Anti-GPR161(1B2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 1B2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2981 | Anti-GPR161(CBLG1-1632) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-1632 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2982 | Anti-GPR161(CBLG1-1633) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-1633 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION